United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Buys 16,612 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• United Super Pty Ltd increased its holdings in Intuitive Surgical, Inc. by 25%, bringing its total stock position to $41.15 million, making it the fund's 24th biggest holding.
• Intuitive Surgical reported a Q2 EPS of $2.19, surpassing analysts' estimates, while its revenue grew by 21.4% to $2.44 billion compared to the same quarter last year.
• Institutional investors hold approximately 83.64% of Intuitive Surgical's stock, reflecting strong interest from large investment firms in the company's growth potential.

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 25.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 83,090 shares of the medical equipment provider's stock after purchasing an additional 16,612 shares during the period. Intuitive Surgical accounts for 1.7% of United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's portfolio, making the stock its 24th largest holding. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's holdings in Intuitive Surgical were worth $41,152,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Chilton Capital Management LLC boosted its stake in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares in the last quarter. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $26,000. Global Financial Private Client LLC lifted its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after buying an additional 38 shares in the last quarter. Elite Financial Inc. acquired a new position in Intuitive Surgical during the 1st quarter worth about $26,000. Finally, Hurley Capital LLC acquired a new position in Intuitive Surgical during the 4th quarter worth about $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In other Intuitive Surgical news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gary S. Guthart sold 2,800 shares of the stock in a transaction that occurred on Monday, July 28th. The shares were sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the completion of the transaction, the insider owned 18,520 shares in the company, valued at $9,171,844.80. This represents a 13.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,903 shares of company stock valued at $7,932,778. 0.70% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG traded up $0.24 during trading on Monday, reaching $483.36. 2,493,317 shares of the company's stock traded hands, compared to its average volume of 2,146,593. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a 50 day moving average of $524.01 and a 200-day moving average of $532.67. The stock has a market capitalization of $173.27 billion, a P/E ratio of 67.41, a price-to-earnings-growth ratio of 5.06 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter in the prior year, the company earned $1.78 earnings per share. The firm's revenue was up 21.4% on a year-over-year basis. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on ISRG shares. Piper Sandler reissued an "overweight" rating and set a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. UBS Group raised their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their target price for the stock from $515.00 to $440.00 in a report on Monday, June 9th. Finally, Citigroup restated a "buy" rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.